Mechanism of Xuanbai Chengqi Decoction and Sangbei Power in Treating Epidemic-closed Lung Type COVID-19

ABSTRACT

Objective: To explore the mechanism of Xuanbai chengqi decoction and Sangbei power in the treatment of epidemic-closed lung type COVID-19 by network pharmacology. Method(s) The potential blood active components and gene targets of Xuanbai chengqi decoction and Sangbei power were screened and predicted by TCMSP;The angiotensin converting enzyme 2(ACE2)related gene targets were downloaded;The PPI network of components-targets was plotted by STRING database.The intersection of ACE2-related genes and target genes of Xuanbai chengqi decoction and Sangbei power was extracted;The DAVID database was used to analyze and screen the key targets and mechanisms of Xuanbai chengqi decoction and Sangbei power. Result(s) A total of 496 active ingredients related to Xuanbai chengqi decoction and Sangbei power were retrieved from TCMSP database.According to the pharmacokinetic parameters, 78 active components in blood were screened and 761 targets were retrieved.5 556 ACE2-related genes were downloaded.49 key genes were obtained after the intersection of Chinese medicine component targets and ACE2 related gene targets;The genes affected by Xuanbai chengqi decoction and Sangbei power were mainly involved in cytoketone metabolism, intracellular protein transport, internal peptidase inhibitor activity and others, which were mainly related to the signaling pathway of the Jak-STAT, the intestinal immune network pathway of producing IgA, complement and coagulation cascade pathway, etc. Conclusion(s) Xuanbai chengqi decoction and Sangbei power can act on ACE2 through 49 gene loci, and its mechanism is related to cellular ketone metabolism and inhibition of protein entry into cells. Copyright © 2021, Central Station of Chinese Medicinal Materials Information, National Medical Products Administration. All right reserved.